 |
Autologous Engineered Skin Substitute |
|---|---|
| Trade Name | Permaderm |
| Orphan Indication | Hospitalized patients with deep partial and full thickness burns requiring grafting |
| USA Market Approval | USA |
| USA Designation Date | 2012-06-01 00:00:00 |
| Sponsor | Amarantus BioScience Holdings, Inc.;655 Montgomery St., Suite 900;San Francisco, California, 94111 |
